PFE P/E Ratio & Valuation Metrics

ShareXLinkedInRedditFacebookWhatsApp

Pfizer Inc. · $28.45 (2026-09-04)

PFE trades at a trailing P/E ratio of 37.4 (forward P/E: 9.8).

Valuation data
Trailing P/E37.43
Forward P/E9.83
PEG Ratio2.79
Price/Book1.90
Price/Sales2.13
EV/EBITDA7.64
EV/Revenue3.36
Members only

Sign in to see the full data

Start Free TrialLog In
About valuation
Valuation metrics compare a company's market price to its fundamentals — earnings, book value, and sales — to gauge whether the stock is cheap or expensive relative to peers and history. No single ratio tells the whole story: fast-growing companies often command higher P/E ratios, while mature, cash-heavy businesses may look cheap on EV/EBITDA. Use these in combination and compare against sector averages.
Frequently asked questions
More on PFE
PFE full analysisDividendPrice Target & ForecastFinancialsKey Statistics
Compare PFE
PFE vs MRNAJNJ vs PFEPFE vs JNJPFE vs MRK
ShareXLinkedInRedditFacebookWhatsApp